Skip to main content
. 2021 Sep 12;22(18):9853. doi: 10.3390/ijms22189853

Figure 10.

Figure 10

A hypothetical model for the regulation of the LXRα-ANGPTL3-LPL pathway by tangeretin. Tangeretin inhibits the mRNA and protein expression of ANGPTL3 by counteracting LXRα-mediated transcriptional activation in hepatic cells, resulting in a restoration of LPL activity, increases in TGRL metabolism, and a reduction in TG levels in circulation.